25 XP   0   0   10

Zhejiang Starry Pharm Co Ltd
Buy, Hold or Sell?

Let's analyse Zhejiang Starry Pharm Co Ltd together

PenkeI guess you are interested in Zhejiang Starry Pharm Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Zhejiang Starry Pharm Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Zhejiang Starry Pharm Co Ltd

I send you an email if I find something interesting about Zhejiang Starry Pharm Co Ltd.

Quick analysis of Zhejiang Starry Pharm Co Ltd (30 sec.)










What can you expect buying and holding a share of Zhejiang Starry Pharm Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.10
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥5.15
Expected worth in 1 year
¥4.88
How sure are you?
91.4%

+ What do you gain per year?

Total Gains per Share
¥0.43
Return On Investment
3.6%

For what price can you sell your share?

Current Price per Share
¥11.93
Expected price per share
¥7.86 - ¥13.62
How sure are you?
50%

1. Valuation of Zhejiang Starry Pharm Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥11.93

Intrinsic Value Per Share

¥12.01 - ¥14.67

Total Value Per Share

¥17.16 - ¥19.82

2. Growth of Zhejiang Starry Pharm Co Ltd (5 min.)




Is Zhejiang Starry Pharm Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$244.1m$285.3m-$40.8m-16.7%

How much money is Zhejiang Starry Pharm Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.9m$4.2m-$6.2m-320.8%
Net Profit Margin-1.3%4.1%--

How much money comes from the company's main activities?

3. Financial Health of Zhejiang Starry Pharm Co Ltd (5 min.)




What can you expect buying and holding a share of Zhejiang Starry Pharm Co Ltd? (5 min.)

Welcome investor! Zhejiang Starry Pharm Co Ltd's management wants to use your money to grow the business. In return you get a share of Zhejiang Starry Pharm Co Ltd.

What can you expect buying and holding a share of Zhejiang Starry Pharm Co Ltd?

First you should know what it really means to hold a share of Zhejiang Starry Pharm Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Zhejiang Starry Pharm Co Ltd is ¥11.93. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Zhejiang Starry Pharm Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Zhejiang Starry Pharm Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥5.15. Based on the TTM, the Book Value Change Per Share is ¥-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.17 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Zhejiang Starry Pharm Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%-0.010.0%0.010.1%0.010.1%0.010.1%
Usd Book Value Change Per Share0.010.1%-0.01-0.1%-0.02-0.2%0.020.1%0.020.2%
Usd Dividend Per Share0.010.1%0.020.2%0.020.2%0.020.2%0.020.2%
Usd Total Gains Per Share0.020.1%0.010.1%0.000.0%0.040.3%0.040.3%
Usd Price Per Share2.14-2.45-5.85-5.90-4.91-
Price to Earnings Ratio327.55-133.93--16.55-82.23-96.07-
Price-to-Total Gains Ratio139.22-45.17--184.52-104.56-136.85-
Price to Book Ratio3.00-3.43-6.79-9.78-10.10-
Price-to-Total Gains Ratio139.22-45.17--184.52-104.56-136.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.651112
Number of shares605
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share-0.010.02
Usd Total Gains Per Share0.010.04
Gains per Quarter (605 shares)8.9321.87
Gains per Year (605 shares)35.7387.47
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
158-2326454277
2117-45629085164
3175-6898135127251
4233-90134180170338
5291-113170225212425
6350-135206270254512
7408-158242315297599
8466-181278360339686
9525-203314406382773
10583-226350451424860

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%32.03.00.091.4%32.03.00.091.4%
Book Value Change Per Share2.02.00.050.0%8.04.00.066.7%16.04.00.080.0%27.07.01.077.1%27.07.01.077.1%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%35.00.00.0100.0%35.00.00.0100.0%
Total Gains per Share3.01.00.075.0%9.03.00.075.0%17.03.00.085.0%32.03.00.091.4%32.03.00.091.4%

Fundamentals of Zhejiang Starry Pharm Co Ltd

About Zhejiang Starry Pharm Co Ltd

Zhejiang Starry Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of X-CT non-ionic contrast agents and fluoroquinolones drugs and intermediates in China and internationally. Its contrast agent products include iohexol, iohexol hydrolysate, iohexol iodide, ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate; and fluoroquinolones products, such as levofloxacin, levofloxacin hydrochloride, levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate. The company was founded in 1997 and is headquartered in Taizhou, China.

Fundamental data was last updated by Penke on 2024-03-27 22:48:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Zhejiang Starry Pharm Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Zhejiang Starry Pharm Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Zhejiang Starry Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 0.7% means that ¥0.01 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Zhejiang Starry Pharm Co Ltd:

  • The MRQ is 0.7%. The company is not making a profit/loss.
  • The TTM is -1.3%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ0.7%TTM-1.3%+2.1%
TTM-1.3%YOY4.1%-5.5%
TTM-1.3%5Y9.3%-10.6%
5Y9.3%10Y10.4%-1.1%
1.1.2. Return on Assets

Shows how efficient Zhejiang Starry Pharm Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Zhejiang Starry Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.1% Return on Assets means that Zhejiang Starry Pharm Co Ltd generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Zhejiang Starry Pharm Co Ltd:

  • The MRQ is 0.1%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.1%TTM-0.3%+0.3%
TTM-0.3%YOY0.6%-0.9%
TTM-0.3%5Y0.9%-1.2%
5Y0.9%10Y1.1%-0.2%
1.1.3. Return on Equity

Shows how efficient Zhejiang Starry Pharm Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Zhejiang Starry Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.2% Return on Equity means Zhejiang Starry Pharm Co Ltd generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Zhejiang Starry Pharm Co Ltd:

  • The MRQ is 0.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ0.2%TTM-0.8%+1.0%
TTM-0.8%YOY1.3%-2.1%
TTM-0.8%5Y2.5%-3.3%
5Y2.5%10Y2.9%-0.4%

1.2. Operating Efficiency of Zhejiang Starry Pharm Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Zhejiang Starry Pharm Co Ltd is operating .

  • Measures how much profit Zhejiang Starry Pharm Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Zhejiang Starry Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Zhejiang Starry Pharm Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM4.8%-4.8%
TTM4.8%YOY10.0%-5.1%
TTM4.8%5Y16.7%-11.8%
5Y16.7%10Y10.8%+5.9%
1.2.2. Operating Ratio

Measures how efficient Zhejiang Starry Pharm Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.65 means that the operating costs are ¥1.65 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Zhejiang Starry Pharm Co Ltd:

  • The MRQ is 1.650. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.681. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.650TTM1.681-0.030
TTM1.681YOY1.625+0.056
TTM1.6815Y1.459+0.222
5Y1.45910Y1.130+0.329

1.3. Liquidity of Zhejiang Starry Pharm Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Zhejiang Starry Pharm Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.82 means the company has ¥0.82 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Zhejiang Starry Pharm Co Ltd:

  • The MRQ is 0.820. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.789. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.820TTM0.789+0.031
TTM0.789YOY0.962-0.173
TTM0.7895Y0.940-0.151
5Y0.94010Y0.597+0.343
1.3.2. Quick Ratio

Measures if Zhejiang Starry Pharm Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Zhejiang Starry Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.11 means the company can pay off ¥0.11 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Zhejiang Starry Pharm Co Ltd:

  • The MRQ is 0.113. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.202. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.113TTM0.202-0.089
TTM0.202YOY0.327-0.125
TTM0.2025Y0.299-0.097
5Y0.29910Y0.302-0.004

1.4. Solvency of Zhejiang Starry Pharm Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Zhejiang Starry Pharm Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Zhejiang Starry Pharm Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.69 means that Zhejiang Starry Pharm Co Ltd assets are financed with 69.1% credit (debt) and the remaining percentage (100% - 69.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Zhejiang Starry Pharm Co Ltd:

  • The MRQ is 0.691. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.678. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.691TTM0.678+0.012
TTM0.678YOY0.597+0.081
TTM0.6785Y0.640+0.038
5Y0.64010Y0.620+0.020
1.4.2. Debt to Equity Ratio

Measures if Zhejiang Starry Pharm Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Zhejiang Starry Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 223.9% means that company has ¥2.24 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Zhejiang Starry Pharm Co Ltd:

  • The MRQ is 2.239. The company is just not able to pay all its debts with equity.
  • The TTM is 2.118. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.239TTM2.118+0.122
TTM2.118YOY1.524+0.594
TTM2.1185Y1.901+0.216
5Y1.90110Y1.738+0.163

2. Market Valuation of Zhejiang Starry Pharm Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Zhejiang Starry Pharm Co Ltd generates.

  • Above 15 is considered overpriced but always compare Zhejiang Starry Pharm Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 327.55 means the investor is paying ¥327.55 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Zhejiang Starry Pharm Co Ltd:

  • The EOD is 252.758. Based on the earnings, the company is expensive. -2
  • The MRQ is 327.547. Based on the earnings, the company is expensive. -2
  • The TTM is 133.933. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD252.758MRQ327.547-74.789
MRQ327.547TTM133.933+193.614
TTM133.933YOY-16.548+150.481
TTM133.9335Y82.235+51.698
5Y82.23510Y96.066-13.831
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Zhejiang Starry Pharm Co Ltd:

  • The EOD is 22.023. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 28.540. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is -97.005. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD22.023MRQ28.540-6.517
MRQ28.540TTM-97.005+125.545
TTM-97.005YOY-1.213-95.792
TTM-97.0055Y-9.974-87.031
5Y-9.97410Y-10.291+0.317
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Zhejiang Starry Pharm Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Zhejiang Starry Pharm Co Ltd:

  • The EOD is 2.316. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.002. Based on the equity, the company is fair priced.
  • The TTM is 3.429. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.316MRQ3.002-0.685
MRQ3.002TTM3.429-0.427
TTM3.429YOY6.788-3.359
TTM3.4295Y9.777-6.348
5Y9.77710Y10.100-0.323
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Zhejiang Starry Pharm Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.045-0.067+250%-0.159+455%0.127-65%0.147-70%
Book Value Per Share--5.1515.1540%6.016-14%4.690+10%3.607+43%
Current Ratio--0.8200.789+4%0.962-15%0.940-13%0.597+37%
Debt To Asset Ratio--0.6910.678+2%0.597+16%0.640+8%0.620+11%
Debt To Equity Ratio--2.2392.118+6%1.524+47%1.901+18%1.738+29%
Dividend Per Share--0.0660.174-62%0.154-57%0.135-51%0.145-54%
Eps--0.012-0.041+446%0.090-87%0.103-89%0.087-86%
Free Cash Flow Per Share--0.135-0.122+190%-0.311+330%-0.050+137%-0.122+190%
Free Cash Flow To Equity Per Share--0.135-0.350+358%-0.121+189%0.110+23%0.093+46%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--14.666--------
Intrinsic Value_10Y_min--12.014--------
Intrinsic Value_1Y_max---0.157--------
Intrinsic Value_1Y_min---0.156--------
Intrinsic Value_3Y_max--0.767--------
Intrinsic Value_3Y_min--0.707--------
Intrinsic Value_5Y_max--3.187--------
Intrinsic Value_5Y_min--2.851--------
Market Cap4086191829.120-30%5295274185.4606059466948.955-13%14486786370.083-63%14615699291.155-64%12147955667.170-56%
Net Profit Margin--0.007-0.013+278%0.041-82%0.093-92%0.104-93%
Operating Margin---0.048-100%0.100-100%0.167-100%0.108-100%
Operating Ratio--1.6501.681-2%1.625+2%1.459+13%1.130+46%
Pb Ratio2.316-30%3.0023.429-12%6.788-56%9.777-69%10.100-70%
Pe Ratio252.758-30%327.547133.933+145%-16.548+105%82.235+298%96.066+241%
Price Per Share11.930-30%15.46017.675-13%42.280-63%42.666-64%35.463-56%
Price To Free Cash Flow Ratio22.023-30%28.540-97.005+440%-1.213+104%-9.974+135%-10.291+136%
Price To Total Gains Ratio107.434-30%139.22345.169+208%-184.519+233%104.563+33%136.848+2%
Quick Ratio--0.1130.202-44%0.327-65%0.299-62%0.302-63%
Return On Assets--0.001-0.003+482%0.006-89%0.009-92%0.011-93%
Return On Equity--0.002-0.008+444%0.013-82%0.025-91%0.029-92%
Total Gains Per Share--0.1110.107+4%-0.005+104%0.261-57%0.292-62%
Usd Book Value--244157110.335244517367.0160%285356228.739-14%222383469.624+10%171034956.763+43%
Usd Book Value Change Per Share--0.006-0.009+250%-0.022+455%0.018-65%0.020-70%
Usd Book Value Per Share--0.7130.7130%0.833-14%0.649+10%0.499+43%
Usd Dividend Per Share--0.0090.024-62%0.021-57%0.019-51%0.020-54%
Usd Eps--0.002-0.006+446%0.013-87%0.014-89%0.012-86%
Usd Free Cash Flow--6419654.107-5783544.245+190%-14775655.292+330%-2364366.431+137%-5124713.488+180%
Usd Free Cash Flow Per Share--0.019-0.017+190%-0.043+330%-0.007+137%-0.017+190%
Usd Free Cash Flow To Equity Per Share--0.019-0.048+358%-0.017+189%0.015+23%0.013+46%
Usd Market Cap565528949.150-30%732865947.268838630225.735-13%2004971233.619-63%2022812781.896-64%1681277064.336-56%
Usd Price Per Share1.651-30%2.1402.446-13%5.852-63%5.905-64%4.908-56%
Usd Profit--559359.304-1940111.631+447%4283614.352-87%4879776.011-89%4116744.806-86%
Usd Revenue--75708045.09482523285.496-8%71495436.968+6%60164345.457+26%45274258.562+67%
Usd Total Gains Per Share--0.0150.015+4%-0.001+104%0.036-57%0.040-62%
 EOD+4 -4MRQTTM+20 -15YOY+13 -225Y+12 -2310Y+13 -22

3.2. Fundamental Score

Let's check the fundamental score of Zhejiang Starry Pharm Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15252.758
Price to Book Ratio (EOD)Between0-12.316
Net Profit Margin (MRQ)Greater than00.007
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.113
Current Ratio (MRQ)Greater than10.820
Debt to Asset Ratio (MRQ)Less than10.691
Debt to Equity Ratio (MRQ)Less than12.239
Return on Equity (MRQ)Greater than0.150.002
Return on Assets (MRQ)Greater than0.050.001
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Zhejiang Starry Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.563
Ma 20Greater thanMa 5011.801
Ma 50Greater thanMa 10011.315
Ma 100Greater thanMa 20013.228
OpenGreater thanClose12.180
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets5,700,496
Total Liabilities3,936,355
Total Stockholder Equity1,757,957
 As reported
Total Liabilities 3,936,355
Total Stockholder Equity+ 1,757,957
Total Assets = 5,700,496

Assets

Total Assets5,700,496
Total Current Assets2,481,475
Long-term Assets3,219,021
Total Current Assets
Cash And Cash Equivalents 803,992
Net Receivables 341,841
Inventory 1,069,998
Other Current Assets 42,370
Total Current Assets  (as reported)2,481,475
Total Current Assets  (calculated)2,258,201
+/- 223,274
Long-term Assets
Property Plant Equipment 2,260,732
Goodwill 404,960
Intangible Assets 317,674
Long-term Assets Other 55,467
Long-term Assets  (as reported)3,219,021
Long-term Assets  (calculated)3,038,833
+/- 180,187

Liabilities & Shareholders' Equity

Total Current Liabilities3,025,714
Long-term Liabilities910,641
Total Stockholder Equity1,757,957
Total Current Liabilities
Short Long Term Debt 1,868,127
Accounts payable 523,591
Other Current Liabilities 460
Total Current Liabilities  (as reported)3,025,714
Total Current Liabilities  (calculated)2,392,178
+/- 633,536
Long-term Liabilities
Long term Debt 813,292
Capital Lease Obligations Min Short Term Debt1,542
Long-term Liabilities  (as reported)910,641
Long-term Liabilities  (calculated)814,835
+/- 95,806
Total Stockholder Equity
Retained Earnings 455,020
Total Stockholder Equity (as reported)1,757,957
Total Stockholder Equity (calculated)455,020
+/- 1,302,937
Other
Capital Stock342,515
Common Stock Shares Outstanding 342,515
Net Debt 1,877,427
Net Invested Capital 4,439,376
Net Working Capital -544,239
Property Plant and Equipment Gross 2,260,732



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-03-312014-12-312013-12-312012-12-312011-12-31
> Total Assets 
724,075
825,376
1,008,888
1,150,475
0
1,399,006
1,478,304
1,879,763
1,816,953
1,832,889
1,893,519
1,952,970
2,042,183
2,023,175
2,013,371
2,091,946
2,041,805
2,153,620
3,066,773
3,227,130
3,258,987
3,416,071
3,484,838
3,568,045
3,783,274
4,317,475
4,406,335
4,315,305
4,349,759
4,569,538
4,895,378
5,150,565
5,156,083
5,310,468
5,302,180
5,523,251
5,454,690
5,700,496
5,700,4965,454,6905,523,2515,302,1805,310,4685,156,0835,150,5654,895,3784,569,5384,349,7594,315,3054,406,3354,317,4753,783,2743,568,0453,484,8383,416,0713,258,9873,227,1303,066,7732,153,6202,041,8052,091,9462,013,3712,023,1752,042,1831,952,9701,893,5191,832,8891,816,9531,879,7631,478,3041,399,00601,150,4751,008,888825,376724,075
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
772,265
796,854
966,372
1,077,196
1,053,346
1,191,771
1,230,503
1,297,528
1,447,146
1,967,927
1,933,564
1,825,547
1,814,682
1,959,999
2,061,807
2,183,283
2,125,625
2,211,594
2,171,639
2,352,091
2,231,714
2,481,475
2,481,4752,231,7142,352,0912,171,6392,211,5942,125,6252,183,2832,061,8071,959,9991,814,6821,825,5471,933,5641,967,9271,447,1461,297,5281,230,5031,191,7711,053,3461,077,196966,372796,854772,2650000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
153,295
182,051
187,121
257,728
250,998
356,004
433,788
428,725
519,687
860,883
799,487
539,814
555,775
651,100
775,740
783,553
689,696
717,692
661,563
778,731
554,921
803,992
803,992554,921778,731661,563717,692689,696783,553775,740651,100555,775539,814799,487860,883519,687428,725433,788356,004250,998257,728187,121182,051153,2950000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30,000
0
0
0
0
0
0
0
0
170,000
130,760
221,197
220,924
170,963
70,158
0
10,017
1,059
877
0
0
0
0008771,05910,017070,158170,963220,924221,197130,760170,0000000000030,0000000000000000000
       Net Receivables 
140,406
92,567
147,334
106,059
0
99,711
143,508
170,991
179,910
152,323
138,844
237,909
278,637
247,321
249,147
289,732
268,437
306,340
327,324
268,216
281,741
303,505
345,398
409,656
456,209
401,570
432,260
519,229
520,047
596,042
676,561
798,887
702,400
626,582
719,493
715,378
560,266
341,841
341,841560,266715,378719,493626,582702,400798,887676,561596,042520,047519,229432,260401,570456,209409,656345,398303,505281,741268,216327,324306,340268,437289,732249,147247,321278,637237,909138,844152,323179,910170,991143,50899,7110106,059147,33492,567140,406
       Other Current Assets 
16,055
7,444
6,220
16,704
0
31,126
30,822
28,487
37,290
97,291
32,571
72,111
36,963
114,377
41,133
112,472
40,457
17,371
22,682
21,632
12,109
8,507
26,429
31,420
23,567
43,531
34,518
38,011
26,999
37,538
21,756
107,849
75,027
103,031
51,123
71,634
106,909
42,370
42,370106,90971,63451,123103,03175,027107,84921,75637,53826,99938,01134,51843,53123,56731,42026,4298,50712,10921,63222,68217,37140,457112,47241,133114,37736,96372,11132,57197,29137,29028,48730,82231,126016,7046,2207,44416,055
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,149,935
2,205,640
2,224,299
2,254,335
2,270,518
2,336,128
2,349,547
2,472,772
2,489,758
2,535,077
2,609,539
2,833,571
2,967,281
3,030,457
3,098,874
3,130,542
3,171,160
3,222,975
3,219,021
3,219,0213,222,9753,171,1603,130,5423,098,8743,030,4572,967,2812,833,5712,609,5392,535,0772,489,7582,472,7722,349,5472,336,1282,270,5182,254,3352,224,2992,205,6402,149,9350000000000000000000
       Property Plant Equipment 
327,272
409,042
531,326
666,887
0
807,344
849,781
856,323
956,172
1,003,171
1,030,618
1,049,319
1,042,261
1,069,314
1,078,346
1,085,173
1,108,220
1,109,408
1,240,460
1,287,484
1,395,062
1,376,414
1,495,865
1,498,575
1,558,070
1,571,402
1,604,090
1,590,226
1,614,088
1,675,818
1,790,540
1,803,376
1,919,921
1,975,084
2,188,740
2,219,119
2,235,427
2,260,732
2,260,7322,235,4272,219,1192,188,7401,975,0841,919,9211,803,3761,790,5401,675,8181,614,0881,590,2261,604,0901,571,4021,558,0701,498,5751,495,8651,376,4141,395,0621,287,4841,240,4601,109,4081,108,2201,085,1731,078,3461,069,3141,042,2611,049,3191,030,6181,003,171956,172856,323849,781807,3440666,887531,326409,042327,272
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
546,125
546,125
546,125
546,125
519,708
519,708
519,708
519,708
519,708
519,708
519,708
519,708
519,708
519,708
519,708
519,708
404,960
404,960
404,960
404,960
404,960404,960404,960404,960519,708519,708519,708519,708519,708519,708519,708519,708519,708519,708519,708519,708546,125546,125546,125546,125000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19,060
19,256
18,319
19,332
19,706
20,149
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000020,14919,70619,33218,31919,25619,0600000000000000000
       Intangible Assets 
34,147
64,509
95,630
106,391
0
104,668
104,575
104,402
104,101
103,339
102,399
101,567
101,121
100,977
100,713
99,855
99,236
98,347
173,548
194,026
59,379
198,401
201,742
203,187
206,592
206,817
207,412
204,388
203,950
205,894
245,592
241,521
298,659
295,831
327,160
324,024
321,159
317,674
317,674321,159324,024327,160295,831298,659241,521245,592205,894203,950204,388207,412206,817206,592203,187201,742198,40159,379194,026173,54898,34799,23699,855100,713100,977101,121101,567102,399103,339104,101104,402104,575104,6680106,39195,63064,50934,147
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
84,906
32,839
64,791
2,649
15,098
16,599
1,589,247
20,573
34,570
56,151
63,083
77,029
151,695
114,068
128,395
28,625
39,341
83,539
55,467
55,46783,53939,34128,625128,395114,068151,69577,02963,08356,15134,57020,5731,589,24716,59915,0982,64964,79132,83984,9060000000000000000000
> Total Liabilities 
422,268
488,570
622,782
718,343
0
961,764
1,020,605
1,066,144
1,017,628
1,018,129
1,066,504
1,097,453
1,196,882
1,161,978
1,140,931
1,197,507
1,164,513
1,257,007
2,143,810
2,268,715
2,282,955
2,391,805
2,456,131
2,488,770
2,680,096
2,483,606
2,541,620
2,368,855
2,339,582
2,495,512
2,680,840
2,869,549
3,262,994
3,451,820
3,530,966
3,742,473
3,703,847
3,936,355
3,936,3553,703,8473,742,4733,530,9663,451,8203,262,9942,869,5492,680,8402,495,5122,339,5822,368,8552,541,6202,483,6062,680,0962,488,7702,456,1312,391,8052,282,9552,268,7152,143,8101,257,0071,164,5131,197,5071,140,9311,161,9781,196,8821,097,4531,066,5041,018,1291,017,6281,066,1441,020,605961,7640718,343622,782488,570422,268
   > Total Current Liabilities 
317,555
412,959
485,655
467,577
0
565,919
644,616
675,179
578,787
567,709
648,833
600,988
556,919
594,740
632,117
692,154
701,221
804,176
1,261,044
1,390,668
1,513,873
1,612,268
1,593,142
1,623,081
1,717,726
1,555,425
1,525,732
1,310,212
1,429,725
1,610,820
1,886,060
2,084,445
2,465,651
2,614,750
2,759,790
2,869,825
3,051,971
3,025,714
3,025,7143,051,9712,869,8252,759,7902,614,7502,465,6512,084,4451,886,0601,610,8201,429,7251,310,2121,525,7321,555,4251,717,7261,623,0811,593,1421,612,2681,513,8731,390,6681,261,044804,176701,221692,154632,117594,740556,919600,988648,833567,709578,787675,179644,616565,9190467,577485,655412,959317,555
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96,400
101,400
120,703
962,604
975,897
1,126,665
1,045,896
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,045,8961,126,665975,897962,604120,703101,40096,4000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
96,400
101,400
120,703
962,604
975,897
1,126,665
1,045,896
1,110,667
1,103,425
1,008,255
827,920
675,717
821,804
908,925
926,920
1,144,650
1,531,955
1,728,140
1,688,792
1,769,989
1,916,015
1,868,127
1,868,1271,916,0151,769,9891,688,7921,728,1401,531,9551,144,650926,920908,925821,804675,717827,9201,008,2551,103,4251,110,6671,045,8961,126,665975,897962,604120,703101,40096,4000000000000000000
       Accounts payable 
79,198
71,139
68,693
91,639
0
81,182
87,435
74,701
73,897
76,873
71,571
62,680
60,251
52,632
62,519
54,772
85,139
184,381
220,933
264,505
326,022
265,847
294,962
268,605
335,571
304,303
295,932
242,760
245,247
387,750
590,944
596,461
478,128
508,323
540,635
519,373
547,601
523,591
523,591547,601519,373540,635508,323478,128596,461590,944387,750245,247242,760295,932304,303335,571268,605294,962265,847326,022264,505220,933184,38185,13954,77262,51952,63260,25162,68071,57176,87373,89774,70187,43581,182091,63968,69371,13979,198
       Other Current Liabilities 
58,856
97,250
88,942
113,560
0
27,189
37,278
29,797
27,089
28,137
38,963
34,008
31,820
37,959
34,929
31,647
19,032
18,147
19,194
120,703
164,345
155,455
17,999
28,842
38,042
34,656
92,969
127,112
128,408
73,958
76,485
91,949
117,669
100,809
83,507
408
92,605
460
46092,60540883,507100,809117,66991,94976,48573,958128,408127,11292,96934,65638,04228,84217,999155,455164,345120,70319,19418,14719,03231,64734,92937,95931,82034,00838,96328,13727,08929,79737,27827,1890113,56088,94297,25058,856
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
878,048
769,082
779,537
862,989
865,689
962,370
928,182
1,015,888
1,058,644
909,857
884,691
794,780
785,103
797,343
837,070
771,176
872,648
651,876
910,641
910,641651,876872,648771,176837,070797,343785,103794,780884,691909,8571,058,6441,015,888928,182962,370865,689862,989779,537769,082878,0480000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-96,400
-101,400
-120,703
-962,604
-975,897
-1,126,665
-1,045,896
0
0
0
0
0
0
0
0
0
0
0
1,538
1,518
1,540
1,542
1,5421,5401,5181,53800000000000-1,045,896-1,126,665-975,897-962,604-120,703-101,400-96,4000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
859,594
750,647
762,837
841,663
844,855
940,031
0
0
0
0
0
4,877
0
0
0
0
0
0
0
00000004,87700000940,031844,855841,663762,837750,647859,5940000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23,070
25,889
29,405
34,048
34,272
37,942
41,109
43,644
24,663
14,436
25,442
25,472
24,841
26,547
41,179
40,757
40,353
44,964
39,054
0
30,768
0
030,768039,05444,96440,35340,75741,17926,54724,84125,47225,44214,43624,66343,64441,10937,94234,27234,04829,40525,88923,0700000000000000000
> Total Stockholder Equity
294,443
330,228
380,385
421,089
432,132
421,314
440,534
795,123
780,680
796,207
810,066
838,125
828,560
844,242
857,183
879,341
862,159
881,977
891,040
928,082
939,813
986,415
995,797
1,042,727
1,068,675
1,796,842
1,823,503
1,896,123
2,004,649
2,069,186
2,174,978
2,252,307
1,891,849
1,853,005
1,765,240
1,775,046
1,744,843
1,757,957
1,757,9571,744,8431,775,0461,765,2401,853,0051,891,8492,252,3072,174,9782,069,1862,004,6491,896,1231,823,5031,796,8421,068,6751,042,727995,797986,415939,813928,082891,040881,977862,159879,341857,183844,242828,560838,125810,066796,207780,680795,123440,534421,314432,132421,089380,385330,228294,443
   Common Stock
90,000
90,000
90,000
90,000
0
90,000
90,000
120,000
120,000
120,000
120,000
120,000
120,000
120,000
120,000
120,000
120,000
120,000
120,000
120,000
167,898
167,898
167,898
167,898
234,956
245,028
244,905
244,905
244,905
245,017
245,017
245,017
343,024
342,914
342,914
342,914
342,914
0
0342,914342,914342,914342,914343,024245,017245,017245,017244,905244,905244,905245,028234,956167,898167,898167,898167,898120,000120,000120,000120,000120,000120,000120,000120,000120,000120,000120,000120,000120,00090,00090,000090,00090,00090,00090,000
   Retained Earnings 
47,876
83,661
133,819
174,523
0
174,747
193,967
219,145
204,702
220,229
234,088
262,147
252,582
268,265
281,205
303,363
286,181
306,000
314,882
288,984
303,306
347,617
449,290
494,945
530,299
589,064
629,344
693,915
662,556
726,404
822,531
902,771
764,176
719,638
624,248
493,521
591,273
455,020
455,020591,273493,521624,248719,638764,176902,771822,531726,404662,556693,915629,344589,064530,299494,945449,290347,617303,306288,984314,882306,000286,181303,363281,205268,265252,582262,147234,088220,229204,702219,145193,967174,7470174,523133,81983,66147,876
   Capital Surplus 00000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-118
1,196
-1,395
896
-1,964
-690
-204
-4,613
-2,344
-3,215
-4,486
-3,809
-5,509
-8,420
-733
4,962
8,928
9,166
21,419
0
021,4199,1668,9284,962-733-8,420-5,509-3,809-4,486-3,215-2,344-4,613-204-690-1,964896-1,3951,196-118000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,385,066
Cost of Revenue-1,832,850
Gross Profit552,216552,216
 
Operating Income (+$)
Gross Profit552,216
Operating Expense-2,183,640
Operating Income201,426-1,631,424
 
Operating Expense (+$)
Research Development140,682
Selling General Administrative128,193
Selling And Marketing Expenses-
Operating Expense2,183,640268,875
 
Net Interest Income (+$)
Interest Income11,608
Interest Expense-107,932
Other Finance Cost-23,590
Net Interest Income-72,734
 
Pretax Income (+$)
Operating Income201,426
Net Interest Income-72,734
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-61,980201,426
EBIT - interestExpense = -107,932
-56,073
51,860
Interest Expense107,932
Earnings Before Interest and Taxes (EBIT)-45,952
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-61,980
Tax Provision--397
Net Income From Continuing Ops-61,583-61,583
Net Income-56,073
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-72,734
 

Technical Analysis of Zhejiang Starry Pharm Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Zhejiang Starry Pharm Co Ltd. The general trend of Zhejiang Starry Pharm Co Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Zhejiang Starry Pharm Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Zhejiang Starry Pharm Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 13.20 < 13.51 < 13.62.

The bearish price targets are: 11.31 > 9.89 > 7.86.

Tweet this
Zhejiang Starry Pharm Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Zhejiang Starry Pharm Co Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Zhejiang Starry Pharm Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Zhejiang Starry Pharm Co Ltd. The current macd is 0.3806838.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Starry Pharm Co Ltd price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Zhejiang Starry Pharm Co Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Zhejiang Starry Pharm Co Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Zhejiang Starry Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartZhejiang Starry Pharm Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Zhejiang Starry Pharm Co Ltd. The current adx is 30.28.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Zhejiang Starry Pharm Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Zhejiang Starry Pharm Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Zhejiang Starry Pharm Co Ltd. The current sar is 13.43.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Zhejiang Starry Pharm Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Zhejiang Starry Pharm Co Ltd. The current rsi is 51.56. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Zhejiang Starry Pharm Co Ltd Daily Relative Strength Index (RSI) ChartZhejiang Starry Pharm Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Zhejiang Starry Pharm Co Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Zhejiang Starry Pharm Co Ltd price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Zhejiang Starry Pharm Co Ltd Daily Stochastic Oscillator ChartZhejiang Starry Pharm Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Zhejiang Starry Pharm Co Ltd. The current cci is 19.06.

Zhejiang Starry Pharm Co Ltd Daily Commodity Channel Index (CCI) ChartZhejiang Starry Pharm Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Zhejiang Starry Pharm Co Ltd. The current cmo is -4.22985417.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Zhejiang Starry Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) ChartZhejiang Starry Pharm Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Zhejiang Starry Pharm Co Ltd. The current willr is -49.70588235.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Zhejiang Starry Pharm Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Zhejiang Starry Pharm Co Ltd Daily Williams %R ChartZhejiang Starry Pharm Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Zhejiang Starry Pharm Co Ltd.

Zhejiang Starry Pharm Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Zhejiang Starry Pharm Co Ltd. The current atr is 0.58902972.

Zhejiang Starry Pharm Co Ltd Daily Average True Range (ATR) ChartZhejiang Starry Pharm Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Zhejiang Starry Pharm Co Ltd. The current obv is -140,506,786.

Zhejiang Starry Pharm Co Ltd Daily On-Balance Volume (OBV) ChartZhejiang Starry Pharm Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Zhejiang Starry Pharm Co Ltd. The current mfi is 70.31.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Zhejiang Starry Pharm Co Ltd Daily Money Flow Index (MFI) ChartZhejiang Starry Pharm Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Zhejiang Starry Pharm Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-06STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-07CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-27CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-31BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-12BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Zhejiang Starry Pharm Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Zhejiang Starry Pharm Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.563
Ma 20Greater thanMa 5011.801
Ma 50Greater thanMa 10011.315
Ma 100Greater thanMa 20013.228
OpenGreater thanClose12.180
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Zhejiang Starry Pharm Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Zhejiang Starry Pharm Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Zhejiang Starry Pharm Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Zhejiang Starry Pharm Co Ltd

I send you an email if I find something interesting about Zhejiang Starry Pharm Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Zhejiang Starry Pharm Co Ltd.

Receive notifications about Zhejiang Starry Pharm Co Ltd in your mailbox!